Literature DB >> 22251397

Topical vitamin A treatment of recalcitrant common warts.

Anca Gaston1, Robert F Garry.   

Abstract

BACKGROUND: Common warts (verruca vulgaris) are benign epithelial proliferations associated with human papillomavirus (HPV) infection. Salicylic acid and cryotherapy are the most frequent treatments for common warts, but can be painful and cause scarring, and have high failure and recrudescence rates. Topical vitamin A has been shown to be a successful treatment of common warts in prior informal studies. CASE: The subject is a healthy, physically-active 30 old female with a 9 year history of common warts on the back of the right hand. The warts resisted treatment with salicylic acid, apple cider vinegar and an over-the-counter blend of essential oils marketed for the treatment of warts. Daily topical application of natural vitamin A derived from fish liver oil (25,000 IU) led to replacement of all the warts with normal skin. Most of the smaller warts had been replaced by 70 days. A large wart on the middle knuckle required 6 months of vitamin A treatment to resolve completely.
CONCLUSION: Retinoids should be further investigated in controlled studies to determine their effectiveness in treating common warts and the broad range of other benign and cancerous lesions induced by HPVs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22251397      PMCID: PMC3274422          DOI: 10.1186/1743-422X-9-21

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  34 in total

1.  Topical retinoids for warts and keratoses in transplant recipients.

Authors:  S Euvrard; M Verschoore; J L Touraine; G Dureau; P Cochat; J Czernielewski; J Thivolet
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

2.  Human papillomavirus detection in dysplastic and malignant oral verrucous lesions.

Authors:  Angela Stokes; Eliete Guerra; Jon Bible; Eugene Halligan; Guy Orchard; Edward Odell; Selvam Thavaraj
Journal:  J Clin Pathol       Date:  2011-12-15       Impact factor: 3.411

3.  The role of the human papillomavirus in oropharyngeal cancer.

Authors:  Aparna Naidu; John M Wright
Journal:  J Mich Dent Assoc       Date:  2011-09

4.  Proliferation of cells and expression of RARs, RXRs and HPV viral E6 and E7 proteins in cervical cancer cell lines after treatment with ATRA.

Authors:  Magdalena Myga-Nowak; Joanna Pacholska-Bogalska; Wojciech Kwaśniewski; Anna Kwaśniewska; Anna Goździcka-Józefiak
Journal:  Ann Agric Environ Med       Date:  2011       Impact factor: 1.447

5.  Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.

Authors:  M D Davis; B S Gostout; R M McGovern; D H Persing; R L Schut; M R Pittelkow
Journal:  J Am Acad Dermatol       Date:  2000-08       Impact factor: 11.527

6.  Treatment of plane warts by tretinoin-induced irritant reaction.

Authors:  M al Aboosi
Journal:  Int J Dermatol       Date:  1994-11       Impact factor: 2.736

7.  Treatment of extensive warts with etretinate: a clinical trial in 20 children.

Authors:  C Gelmetti; D Cerri; A A Schiuma; S Menni
Journal:  Pediatr Dermatol       Date:  1987-11       Impact factor: 1.588

8.  p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation.

Authors:  Kristen K Mighty; Laimonis A Laimins
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

9.  Molecular cloning and characterization of human papillomavirus type 7 DNA.

Authors:  T Oltersdorf; M S Campo; M Favre; K Dartmann; L Gissmann
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

10.  Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation.

Authors:  C Agarwal; E A Rorke; J C Irwin; R L Eckert
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

View more
  1 in total

Review 1.  HPV Carcinomas in Immunocompromised Patients.

Authors:  Nicole M Reusser; Christopher Downing; Jacqueline Guidry; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-01-29       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.